H Mehmet. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAnimalsApoptosisBrain/metabolismBrain/pathologyBrain Ischemia/metabolismBrain Ischemia/pathologyFas Ligand ProteinHumansInfarction, Middle Cerebral Artery/drug therapyInfarction, Middle Cerebral Artery/geneticsInfarction, Middle Cerebral Artery/metabolismMembrane Glycoproteins/antagonists & inhibitorsMembrane Glycoproteins/geneticsMembrane Glycoproteins/metabolismMiceMice, KnockoutStroke/drug therapyStroke/geneticsStroke/metabolismStroke/pathologyTumor Necrosis Factor-alpha/antagonists & inhibitorsTumor Necrosis Factor-alpha/geneticsTumor Necrosis Factor-alpha/metabolism
Substances： See more » FASLG protein, humanFas Ligand ProteinFasl protein, mouseMembrane GlycoproteinsTumor Necrosis Factor-alpha
Year: 2001 PMID： 11464209 DOI： 10.1038/sj.cdd.4400899
Source DB: PubMed Journal: Cell Death Differ ISSN： 1350-9047 Impact factor: 15.828